Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Does CRISPR-Cas open new possibilities for patents or present a moral maze?

CRISPR-Cas systems, which enable the production of new artificial genes, synthetic proteins and new transgenic organisms, will challenge patent practices worldwide.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Jinek, M. et al. Science 337, 816–821 (2012).

    CAS  Article  Google Scholar 

  2. Jiang, W. et al. Nat. Biotechnol. 31, 233–239 (2013).

    CAS  Article  Google Scholar 

  3. Cho, S.W. et al. Nat. Biotechnol. 31, 230–232 (2013).

    CAS  Article  Google Scholar 

  4. Hwang, W.Y. et al. Nat. Biotechnol. 31, 227–229 (2013).

    CAS  Article  Google Scholar 

  5. Urnov, F.D. et al. Nat. Rev. Genet. 11, 636–646 (2010).

    CAS  Article  Google Scholar 

  6. Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al. http://www.supremecourt.gov/opinions/12pdf/12-398_1b7d.pdf (13 June 2013).

  7. Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, Official Journal L213, 0013–0021 (30 July 1998). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31998L0044:EN:HTML

  8. Diamond v. Chakrabarty, 447 US 303 (1980).

  9. Patent no. 3, granted in Finland in 1843.

  10. Plant Genetics Systems NV and Biogen, Inc. European Patent No. 0 242 236 (10 October 1990).

  11. T0356/93 Plant cells/Plant Genetic Systems http://www.epo.org/law-practice/case-law-appeals/recent/t930356ep1.html

  12. T 0019/90 Onco-Mouse/Harvard http://www.epo.org/law-practice/case-law-appeals/recent/t900019ex1.html.

  13. Recital 16 of the Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, Official Journal L213, 0013–0021 (30 July 1998). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31998L0044:EN:HTML

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip Webber.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Webber, P. Does CRISPR-Cas open new possibilities for patents or present a moral maze?. Nat Biotechnol 32, 331–333 (2014). https://doi.org/10.1038/nbt.2843

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2843

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing